This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Advertisement


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit July 13, 2016

SLAS.org    SLAS2017    Moving? New job? Let SLAS know.      

Advertisement

Advertisement





 




news


SLAS Europe Council Seeks Candidates: Respond by Aug. 24
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
Individuals who wish to serve on the SLAS Europe Council are invited to submit materials for consideration by midnight CET, Wednesday, Aug. 24. Nomination materials include current CV, a short statement of your reasons for seeking a position and an affidavit acknowledging your eligibility to serve.

The current SLAS Europe Council will review submitted materials and select a slate to fill three open spots on the Council; the slate will be presented to all SLAS members in the Europe Region in October. The new Council members will replace Emilio Diez-Monedero, Steve Rees and Burkhard Schaefer, whose terms expire in 2016.
More


Advertisement


SLAS ELN Reports: Anti-Leaching Solutions Featured on SLAS2016 Innovation AveNEW
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Read the latest SLAS Electronic Laboratory Neighborhood e-zine article about the magic that happens when connections are made through participation in SLAS. Longtime SLAS member Amer El-Hage saw how a medical products company could help with issues being discussed in the SLAS Labware Leachables Special Interest Group, so he brought SIG Chair Lynn Rasmussen together with SiO2 Medical Product's Brian Maurer.

The discussions led to a new market for SiO2 and the company's spot on SLAS2016 Innovation AveNEW. Read the full story and learn more about other SLAS Innovation AveNEW companies in the e-zine.
More


Advertisement
Sponsored Content


SLAS2017 Call for Scientific Podium Presentations
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Are you leveraging the power of new technologies to achieve scientific objectives? SLAS members want to know the details. Submit a scientific presentation abstract by Aug. 8 for the opportunity to showcase your research on the global stage of SLAS2017, Feb. 4-8, Washington, DC.

Detailed information on seven scientific tracks, including overall descriptions, session titles and track and session chairs are now online. The SLAS2017 Scientific Program Committee is looking for innovation, relevance and applicability. While you are at it, take our short and fun quiz to find out what reagent color best suits your scientific personality.
More




Advertisement
Welcome to RAD Source
Since 1997 Rad Source Technologies has been the expert in providing renewable, non-isotope, ionizing radiation replacements for self-shielded gamma irradiators. Currently, there are over 300 renowned hospital, university, and pharmaceutical research institutions using Rad Source X-ray technology. To find out more about our equipment, select your application and you will find equipment specifications, literature references, white papers, training videos, discussion forums, as well as other helpful info.


Help Readers Find Your Journal Article
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
SAGE Publishing offers tips for effective publication of scientific work through optimization for search engines. According to a SAGE website resource, "Google and Google Scholar are the principal ways in which people will find your article online today. Between them they account for 60% of referral traffic to SAGE Journals Online. The search engine is now the first port of call for researchers and it is of paramount importance your article can be found easily in search engine results."

Repeat key phrases in the abstract while writing naturally, get the title right and choose your key words carefully are among the strategies the SLAS journals publisher recommends. Read about additional resources, like Kudos and ORCID, on the SLAS website.
More


Advertisement


SLAS2017 Special Session: Regenerative Medicine — Next Generation Treatments
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Regenerative medicine is having a big impact on the future of medicine with its potential to fully repair damaged cells, tissues and organs. Developments in stem cell technology, tissue engineering and molecular biology are pushing the frontiers of medicine by providing the possibility of cures through the use of cellular therapies. The next decade will see the rapid development of treatments that will employ human iPS cells, drugs and biologics as substrates for therapies in acute and chronic diseases.

In this SLAS2017 session, presenters explore the recent advances in the generation, standardization, characterization and the mechanistic behavior of stem cells and their applications in regenerative medicine. Session chairs are G. Sitta Sittampalam from the National Institutes of Health and Marcie Glicksman of ORIG3N and SLAS2017 conference co-chair.
More




Advertisement
Superior Mass Spec Results Start with Superior Protein Sample Prep

Agilent AssayMAP automated protein and peptide sample preparation gives you greater throughput, precision, and reproducibility.


news


Skin Cancer Tracked From (Stem) Cell of Origin
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Investigations into cancer's ultimate origins bring to mind the "want of a nail" proverb, a reminder that a small initial dysfunction can trigger a chain of increasingly serious problems that culminate in disaster. Yet these investigations have had difficulty nailing down the oncogenic, well, nail. Must cancer originate in a stem cell, or may it originate in a progenitor cell? An answer to this question comes from scientists based at Université Libre de Bruxelles and the University of Cambridge. More


High-Field-Effect Mobility of Low-Crystallinity Conjugated Polymers with Localized Aggregates
Journal of the American Chemical Society    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Charge carriers typically move faster in crystalline regions than in amorphous regions in conjugated polymers because polymer chains adopt a regular arrangement resulting in a high degree of π–π stacking in crystalline regions. In contrast, the random polymer chain orientation in amorphous regions hinders connectivity between conjugated backbones; thus, it hinders charge carrier delocalization. Various studies have attempted to enhance charge carrier transport by increasing crystallinity. More


Advertisement
Sponsored Content


New Microfluidic Device Offers Means for Studying Electric Field Cancer Therapy
Phys.org    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at MIT's research center in Singapore have developed a new microfluidic device that tests the effects of electric fields on cancer cells. They observed that a range of low-intensity, middle-frequency electric fields effectively stopped breast and lung cancer cells from growing and spreading, while having no adverse effect on neighboring healthy cells. The device, about the size of a U.S. dollar coin, is designed to help scientists narrow in on safe ranges of electric fields to noninvasively treat breast, lung, and other forms of cancer. More


New Clues Could Help Scientists Harness the Power of Photosynthesis
Lab Manager    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Identification of a gene needed to expand light harvesting in photosynthesis into the far-red-light spectrum provides clues to the development of oxygen-producing photosynthesis, an evolutionary advance that changed the history of life on Earth. "Knowledge of how photosynthesis evolved could empower scientists to design better ways to use light energy for the benefit of mankind," said Donald A. Bryant, the Ernest C. Pollard Professor of Biotechnology and professor of biochemistry and molecular biology at Penn State University. More




Survey Finds Laissez-Faire Attitude Toward Validating Antibodies
Science Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
James Anderson studies how epithelial cells that act as barriers within cells, tissue, or organs are bound together. In his lab at the National Heart, Lung, and Blood Institute on the Bethesda, Maryland, campus of the National Institutes of Health, the cell biologist uses antibodies to tag the proteins he and his colleagues are looking for, but only after making sure they are labeling with the proper antibody. To do without such baseline information, the entire experiment could be irreproducible. More


Federal Study of MCHM Concludes
Chemical & Engineering News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A just-released federal study of 4-methylcyclohexanemethanol (MCHM) concluded that exposure to the chemical after it spilled into the Elk River in Charleston, W. Va., in January 2014 is "not likely to be associated with any adverse health effects." MCHM was the largest component of a mixture of chemicals that leaked from a corroded commercial storage tank upstream of the water supply for some 300,000 people. At the time of the spill, little was known about MCHM, an alicyclic alcohol used to process coal. More


Composite Endpoints in Clinical Trials
The Scientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
It's a moment every clinical researcher dreads: you crunch the numbers for an upcoming trial and realize you'll need to recruit tens of thousands of participants to show a statistically significant effect for the therapy you're testing. You don't see any way to change most of your variables linked to trial size. But what if you change your endpoints? In recent years, a growing number of clinical trials have used composite endpoints — multiple events all treated as one endpoint — as a way to boost the power of a study so that fewer participants are needed. More


Gene Sequencing Offers Way to Beat Global Spread of Gonorrhea
Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
With drug-resistant strains of sexually-transmitted infection gonorrhoeae increasing, scientists from Brighton, Oxford University and Public Health England have found that genetic sequencing can track the spread of infection. They show coordinated national and international strategies are required to stop drug-resistance spreading further. Their study, funded by the National Institute for Health Research Oxford Biomedical Research Centre and the NIHR Healthcare-Associated Infections and Antimicrobial Resistance Health Protection Research Unit, is published in The Lancet Infectious Diseases. More


Career


Phase 1 Experimental Therapeutics Program Director
Childrens Mercy Hospital
US – MO – Kansas City

Senior QC Microbiologist II
Astellas
US – CA – Santa Monica

The Klein Endowed Chair in Alzheimer's Disease and Neurodegeneration Research
Rutgers Brain Health Institute
US – NJ – Piscataway

Search Jobs at SLAS Career Connections


news

 
SLAS Point-to-Point
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Dennis Hall, Executive Editor, 469.420.2656   
Contribute news

This edition of SLAS Point-to-Point was sent to ##Email##. To unsubscribe from receiving SLAS Point-to-Point, click here. To unsubscribe from all SLAS e-mail communications, please click here. Did someone forward this edition to you? Subscribe here — it's free!

SLAS Terms of Use Policy
Recent issues

July 6, 2016
June 29, 2016
June 22, 2016
June 15, 2016



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063